Journey Medical

DERMPhase 3

Founded 2014journeymedicalcorp.com

Journey Medical, founded in 2014, operates as a specialized dermatology commercialization engine, identifying and acquiring established or late-stage prescription products. Its mission is to positively impact patients' lives by providing effective treatments for skin conditions, wounds, and overall skin health. The company is led by a team with deep dermatology commercialization experience, including executives from Medicis Pharmaceutical, and went public in 2021. Its strategy centers on leveraging its focused commercial infrastructure to maximize the value of its product portfolio.

Market Cap

$220.5M

Founded

2014

Focus

Small Molecules

AI Company Overview

Technology Platform

Journey Medical's core platform is its specialized commercial and operational model for acquiring and efficiently commercializing approved dermatology products, leveraging deep therapeutic area expertise and a targeted sales force.

Pipeline Snapshot

7 drugs in pipeline, 3 in Phase 3

Drug	Indication	Stage
glycopyrronium Topical Wipes	Hyperhidrosis	Phase 3
glycopyrronium Topical Wipes	Hyperhidrosis	Phase 3
Glycopyrronium Topical Wipes	Hyperhidrosis	Phase 3
glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate, 3.0% + glycopyrrol...	Hyperhidrosis	Phase 2
Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 o...	Hyperhidrosis	Phase 2

Funding History

Total raised: $45M

IPO$25MUndisclosedNov 5, 2021

Series A$15MUndisclosedJun 15, 2015

Seed$5MUndisclosedJun 15, 2014

Opportunities

The large and growing dermatology therapeutics market offers a steady stream of acquisition targets.

Journey can leverage its focused commercial model to unlock value from under-commercialized products.

Its public status provides currency for deals and potential access to capital for strategic acquisitions.

Risk Factors

Growth is highly dependent on successful acquisitions and integration.

Revenue concentration in key products like Accutane creates vulnerability.

The company faces intense competition for both market share and acquisition targets, alongside stringent regulatory requirements for its products.

Competitive Landscape

Journey Medical competes with large pharma dermatology divisions, pure-play dermatology companies, and other specialty pharma acquirers. Its key differentiation is its lean, expert commercial team solely focused on dermatology, allowing for deep customer relationships and efficient operations compared to larger, less-focused competitors.